Propanc Receives Additional $525,000 from Institutional Investor; Initiates Animal Safety Toxicology Studies for PRP Jan 13, 2016
Propanc Makes Substantial Progress With Lead Patent Application for New Cancer Treatment in Key Global Regions May 23, 2014